Gastric motility drugs, also known as prokinetic drugs, are drugs that promote the forward movement of gastrointestinal contents. When gastric motility is low, the emptying of gastric contents is delayed, which can cause many gastrointestinal diseases, such as nausea, vomiting, heartburn, postprandial discomfort, dyspepsia, etc., and can cause gastroesophageal reflux, leading to esophageal ulcer. Gastric motility drugs are used clinically to treat related diseases, such as reflux symptoms, reflux esophagitis, dyspepsia, intestinal obstruction and other common diseases.

This report aims to provide a comprehensive study of the global market for Gastric Motility Drugs. Report Highlights:

(1) Global Gastric Motility Drugs market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Gastric Motility Drugs market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(3) China Gastric Motility Drugs market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(4) Global Gastric Motility Drugs segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Gastric Motility Drugs segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Gastric Motility Drugs, capacity, production and trends.

(7) Gastric Motility Drugs industry supply chain, upstream, midstream and downstream analysis.

According to latest study, the global market for Gastric Motility Drugs should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Gastric Motility Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Gastric Motility Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Monotherapy segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Chronic Gastritis has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Gastric Motility Drugs include Johnson & Johnson, Sumitomo Dainippon, Sanofi, Pfizer, Teva, GrupoFarma, Abbott, Kyowa Kirin and Sigma-Tau Group, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Monotherapy

Poly Pill

Market segment by application, can be divided into

Chronic Gastritis

Reflux Esophagitis

Functional Dyspepsia

Others

Market segment by players, this report covers

Johnson & Johnson

Sumitomo Dainippon

Sanofi

Pfizer

Teva

GrupoFarma

Abbott

Kyowa Kirin

Sigma-Tau Group

Wilmington

Chengdu Kanghong Pharmaceutical Group Co.,Ltd

Lunan Pharmaceutical Group Corporation

Hansoh Pharmaceutical Group Company Limited

Shanghai Sine Pharmaceutical Laboratories Co., Ltd

Disha Pharmaceutical Group Co., Ltd

Xian Janssen Pharmaceutical Ltd

1 Market Overview

1.1 Gastric Motility Drugs Definition

1.2 Global Gastric Motility Drugs Market Size and Forecast

1.2.1 By Revenue, Global Gastric Motility Drugs Market Size, 2018-2029

1.2.2 By Sales Volume, Global Gastric Motility Drugs Market Size, 2018-2029

1.2.3 Global Gastric Motility Drugs Price Trend, 2018-2029

1.3 China Gastric Motility Drugs Market Size and Forecast

1.3.1 By Revenue, China Gastric Motility Drugs Market Size, 2018-2029

1.3.2 By Sales Volume, China Gastric Motility Drugs Market Size, 2018-2029

1.3.3 China Gastric Motility Drugs Price Trend, 2018-2029

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Gastric Motility Drugs Share in Global Market, 2018-2029

1.4.2 By Sales Volume, China Gastric Motility Drugs Share in Global Market, 2018-2029

1.4.3 Gastric Motility Drugs Market Size: China VS Global, 2018-2029

1.5 Gastric Motility Drugs Market Dynamics

1.5.1 Gastric Motility Drugs Market Drivers

1.5.2 Gastric Motility Drugs Market Restraints

1.5.3 Gastric Motility Drugs Industry Trends

1.5.4 Gastric Motility Drugs Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Gastric Motility Drugs Revenue by Company, 2018-2023

2.2 Global Gastric Motility Drugs Sales Volume by Company, 2018-2023

2.3 Global Gastric Motility Drugs Price by Company, 2018-2023

2.4 Global Gastric Motility Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Gastric Motility Drugs Concentration Ratio

2.6 Global Gastric Motility Drugs Mergers & Acquisitions, Expansion Plans

2.7 Global Gastric Motility Drugs Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Gastric Motility Drugs Revenue by Company, 2018-2023

3.2 China Gastric Motility Drugs Sales Volume by Company, 2018-2023

3.3 China Gastric Motility Drugs Gastric Motility Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Gastric Motility Drugs Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)

3.5 Chinese Local Players, Gastric Motility Drugs Domestic VS Export

3.6 China Market, Gastric Motility Drugs Import & Export

3.6.1 China Market, Gastric Motility Drugs Import & Export, 2018-2029

3.6.2 China Gastric Motility Drugs Import & Export Trends

3.6.3 Main Sources of China Gastric Motility Drugs Import

3.6.4 Export Destination of China Gastric Motility Drugs

4 Gastric Motility Drugs Production by Region

4.1 Global Gastric Motility Drugs Capacity, Production and Capacity Utilization, 2018-2029

4.2 Global Geographic Distribution of Gastric Motility Drugs Manufacturers

4.3 Global Major Manufacturers, Gastric Motility Drugs Capacity Expansion and Future Plans

4.4 Global Gastric Motility Drugs Capacity by Region

4.5 Global Gastric Motility Drugs Production by Region

4.5.1 Global Gastric Motility Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029

4.5.2 Global Gastric Motility Drugs Production by Region, 2018-2023

4.5.3 Global Gastric Motility Drugs Production Market Share & Forecast by Region, 2018-2029

5 Industry Chain Analysis

5.1 Gastric Motility Drugs Industry Chain

5.2 Gastric Motility Drugs Upstream Analysis

5.2.1 Gastric Motility Drugs Core Raw Materials

5.2.2 Main Manufacturers of Gastric Motility Drugs Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Gastric Motility Drugs Production Mode

5.6 Gastric Motility Drugs Procurement Model

5.7 Gastric Motility Drugs Industry Sales Model and Sales Channels

5.7.1 Gastric Motility Drugs Sales Model

5.7.2 Gastric Motility Drugs Typical Distributors

6 Sights by Type

6.1 Gastric Motility Drugs Classification

6.1.1 Monotherapy

6.1.2 Poly Pill

6.2 By Type, Global Gastric Motility Drugs Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Type, Global Gastric Motility Drugs Revenue, 2018-2029

6.4 By Type, Global Gastric Motility Drugs Sales Volume, 2018-2029

6.5 By Type, Global Gastric Motility Drugs Price, 2018-2029

7 Sights by Application

7.1 Gastric Motility Drugs Segment by Application

7.1.1 Chronic Gastritis

7.1.2 Reflux Esophagitis

7.1.3 Functional Dyspepsia

7.1.4 Others

7.2 By Application, Global Gastric Motility Drugs Market Size & CAGR, 2018 VS 2022 VS 2029

7.3 By Application, Global Gastric Motility Drugs Revenue, 2018-2029

7.4 By Application, Global Gastric Motility Drugs Sales Volume, 2018-2029

7.5 By Application, Global Gastric Motility Drugs Price, 2018-2029

8 Sales Sights by Region

8.1 By Region, Global Gastric Motility Drugs Market Size, 2018 VS 2022 VS 2029

8.2 By Region, Global Gastric Motility Drugs Revenue, 2018-2029

8.3 By Region, Global Gastric Motility Drugs Sales Volume, 2018-2029

8.4 North America

8.4.1 North America Gastric Motility Drugs Market Size & Forecasts, 2018-2029

8.4.2 By Country, North America Gastric Motility Drugs Market Size Market Share

8.5 Europe

8.5.1 Europe Gastric Motility Drugs Market Size & Forecasts, 2018-2029

8.5.2 By Country, Europe Gastric Motility Drugs Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Gastric Motility Drugs Market Size & Forecasts, 2018-2029

8.6.2 By Country/Region, Asia Pacific Gastric Motility Drugs Market Size Market Share

8.7 South America

8.7.1 South America Gastric Motility Drugs Market Size & Forecasts, 2018-2029

8.7.2 By Country, South America Gastric Motility Drugs Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Gastric Motility Drugs Market Size & CAGR，2018 VS 2022 VS 2029

9.2 By Country, Global Gastric Motility Drugs Revenue, 2018-2029

9.3 By Country, Global Gastric Motility Drugs Sales Volume, 2018-2029

9.4 U.S.

9.4.1 U.S. Gastric Motility Drugs Market Size, 2018-2029

9.4.2 By Company, U.S. Gastric Motility Drugs Sales Volume Market Share, 2022

9.4.3 By Type, U.S. Gastric Motility Drugs Market Size, Share, 2022 VS 2029

9.4.4 By Application, U.S. Gastric Motility Drugs Market Size, Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe Gastric Motility Drugs Market Size, 2018-2029

9.5.2 By Company, Europe Gastric Motility Drugs Sales Volume Market Share, 2022

9.5.3 By Type, Europe Gastric Motility Drugs Market Size, Share, 2022 VS 2029

9.5.4 By Application, Europe Gastric Motility Drugs Market Size, Share, 2022 VS 2029

9.6 China

9.6.1 China Gastric Motility Drugs Market Size, 2018-2029

9.6.2 By Company, China Gastric Motility Drugs Sales Volume Market Share, 2022

9.6.3 By Type, China Gastric Motility Drugs Market Size, Share, 2022 VS 2029

9.6.4 By Application, China Gastric Motility Drugs Market Size, Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan Gastric Motility Drugs Market Size, 2018-2029

9.7.2 By Company, Japan Gastric Motility Drugs Sales Volume Market Share, 2022

9.7.3 By Type, Japan Gastric Motility Drugs Market Size, Share, 2022 VS 2029

9.7.4 By Application, Japan Gastric Motility Drugs Market Size, Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea Gastric Motility Drugs Market Size, 2018-2029

9.8.2 By Company, South Korea Gastric Motility Drugs Sales Volume Market Share, 2022

9.8.3 By Type, South Korea Gastric Motility Drugs Market Size, Share, 2022 VS 2029

9.8.4 By Application, South Korea Gastric Motility Drugs Market Size, Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia Gastric Motility Drugs Market Size, 2018-2029

9.9.2 By Company, Southeast Asia Gastric Motility Drugs Sales Volume Market Share, 2022

9.9.3 By Type, Southeast Asia Gastric Motility Drugs Market Size, Share, 2022 VS 2029

9.9.4 By Application, Southeast Asia Gastric Motility Drugs Market Size, Share, 2022 VS 2029

9.10 India

9.10.1 India Gastric Motility Drugs Market Size, 2018-2029

9.10.2 By Company, India Gastric Motility Drugs Sales Volume Market Share, 2022

9.10.3 By Type, India Gastric Motility Drugs Market Size, Share, 2022 VS 2029

9.10.4 By Application, India Gastric Motility Drugs Market Size, Share, 2022 VS 2029

9.11 Middle East & Asia

9.11.1 Middle East & Asia Gastric Motility Drugs Market Size, 2018-2029

9.11.2 By Company, Middle East & Asia Gastric Motility Drugs Sales Volume Market Share, 2022

9.11.3 By Type, Middle East & Asia Gastric Motility Drugs Market Size, Share, 2022 VS 2029

9.11.4 By Application, Middle East & Asia Gastric Motility Drugs Market Size, Share, 2022 VS 2029

10 Manufacturers Profile

10.1 Johnson & Johnson

10.1.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position

10.1.2 Johnson & Johnson Gastric Motility Drugs Models, Specifications and Application

10.1.3 Johnson & Johnson Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.1.4 Johnson & Johnson Company Profile and Main Business

10.1.5 Johnson & Johnson Recent Developments

10.2 Sumitomo Dainippon

10.2.1 Sumitomo Dainippon Company Information, Head Office, Market Area and Industry Position

10.2.2 Sumitomo Dainippon Gastric Motility Drugs Models, Specifications and Application

10.2.3 Sumitomo Dainippon Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.2.4 Sumitomo Dainippon Company Profile and Main Business

10.2.5 Sumitomo Dainippon Recent Developments

10.3 Sanofi

10.3.1 Sanofi Company Information, Head Office, Market Area and Industry Position

10.3.2 Sanofi Gastric Motility Drugs Models, Specifications and Application

10.3.3 Sanofi Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.3.4 Sanofi Company Profile and Main Business

10.3.5 Sanofi Recent Developments

10.4 Pfizer

10.4.1 Pfizer Company Information, Head Office, Market Area and Industry Position

10.4.2 Pfizer Gastric Motility Drugs Models, Specifications and Application

10.4.3 Pfizer Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.4.4 Pfizer Company Profile and Main Business

10.4.5 Pfizer Recent Developments

10.5 Teva

10.5.1 Teva Company Information, Head Office, Market Area and Industry Position

10.5.2 Teva Gastric Motility Drugs Models, Specifications and Application

10.5.3 Teva Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.5.4 Teva Company Profile and Main Business

10.5.5 Teva Recent Developments

10.6 GrupoFarma

10.6.1 GrupoFarma Company Information, Head Office, Market Area and Industry Position

10.6.2 GrupoFarma Gastric Motility Drugs Models, Specifications and Application

10.6.3 GrupoFarma Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.6.4 GrupoFarma Company Profile and Main Business

10.6.5 GrupoFarma Recent Developments

10.7 Abbott

10.7.1 Abbott Company Information, Head Office, Market Area and Industry Position

10.7.2 Abbott Gastric Motility Drugs Models, Specifications and Application

10.7.3 Abbott Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.7.4 Abbott Company Profile and Main Business

10.7.5 Abbott Recent Developments

10.8 Kyowa Kirin

10.8.1 Kyowa Kirin Company Information, Head Office, Market Area and Industry Position

10.8.2 Kyowa Kirin Gastric Motility Drugs Models, Specifications and Application

10.8.3 Kyowa Kirin Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.8.4 Kyowa Kirin Company Profile and Main Business

10.8.5 Kyowa Kirin Recent Developments

10.9 Sigma-Tau Group

10.9.1 Sigma-Tau Group Company Information, Head Office, Market Area and Industry Position

10.9.2 Sigma-Tau Group Gastric Motility Drugs Models, Specifications and Application

10.9.3 Sigma-Tau Group Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.9.4 Sigma-Tau Group Company Profile and Main Business

10.9.5 Sigma-Tau Group Recent Developments

10.10 Wilmington

10.10.1 Wilmington Company Information, Head Office, Market Area and Industry Position

10.10.2 Wilmington Gastric Motility Drugs Models, Specifications and Application

10.10.3 Wilmington Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.10.4 Wilmington Company Profile and Main Business

10.10.5 Wilmington Recent Developments

10.11 Chengdu Kanghong Pharmaceutical Group Co.,Ltd

10.11.1 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Company Information, Head Office, Market Area and Industry Position

10.11.2 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Models, Specifications and Application

10.11.3 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.11.4 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Company Profile and Main Business

10.11.5 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Recent Developments

10.12 Lunan Pharmaceutical Group Corporation

10.12.1 Lunan Pharmaceutical Group Corporation Company Information, Head Office, Market Area and Industry Position

10.12.2 Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Models, Specifications and Application

10.12.3 Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.12.4 Lunan Pharmaceutical Group Corporation Company Profile and Main Business

10.12.5 Lunan Pharmaceutical Group Corporation Recent Developments

10.13 Hansoh Pharmaceutical Group Company Limited

10.13.1 Hansoh Pharmaceutical Group Company Limited Company Information, Head Office, Market Area and Industry Position

10.13.2 Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Models, Specifications and Application

10.13.3 Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.13.4 Hansoh Pharmaceutical Group Company Limited Company Profile and Main Business

10.13.5 Hansoh Pharmaceutical Group Company Limited Recent Developments

10.14 Shanghai Sine Pharmaceutical Laboratories Co., Ltd

10.14.1 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Company Information, Head Office, Market Area and Industry Position

10.14.2 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Models, Specifications and Application

10.14.3 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.14.4 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Company Profile and Main Business

10.14.5 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Recent Developments

10.15 Disha Pharmaceutical Group Co., Ltd

10.15.1 Disha Pharmaceutical Group Co., Ltd Company Information, Head Office, Market Area and Industry Position

10.15.2 Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Models, Specifications and Application

10.15.3 Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.15.4 Disha Pharmaceutical Group Co., Ltd Company Profile and Main Business

10.15.5 Disha Pharmaceutical Group Co., Ltd Recent Developments

10.16 Xian Janssen Pharmaceutical Ltd

10.16.1 Xian Janssen Pharmaceutical Ltd Company Information, Head Office, Market Area and Industry Position

10.16.2 Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Models, Specifications and Application

10.16.3 Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.16.4 Xian Janssen Pharmaceutical Ltd Company Profile and Main Business

10.16.5 Xian Janssen Pharmaceutical Ltd Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Gastric Motility Drugs Market Size & CAGR: China VS Global, 2018-2029, US$ Million_x000D_

Table 2. Gastric Motility Drugs Market Restraints_x000D_

Table 3. Gastric Motility Drugs Market Trends_x000D_

Table 4. Gastric Motility Drugs Industry Policy_x000D_

Table 5. Global Gastric Motility Drugs Revenue by Company, 2018-2023, US$ million_x000D_

Table 6. Global Gastric Motility Drugs Revenue Market Share by Company, 2018-2023_x000D_

Table 7. Global Gastric Motility Drugs Sales Volume by Company, 2018-2023, (K Units)_x000D_

Table 8. Global Gastric Motility Drugs Sales Volume Market Share by Company, 2018-2023_x000D_

Table 9. Global Gastric Motility Drugs Price by Company, 2018-2023, (US$/Unit)_x000D_

Table 10. Global Gastric Motility Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)_x000D_

Table 11. Global Gastric Motility Drugs Mergers & Acquisitions, Expansion Plans_x000D_

Table 12. Global Gastric Motility Drugs Manufacturers Product Type_x000D_

Table 13. China Gastric Motility Drugs Revenue by Company, 2018-2023, US$ million_x000D_

Table 14. China Gastric Motility Drugs Revenue Market Share by Company, 2018-2023_x000D_

Table 15. China Gastric Motility Drugs Sales Volume by Company, 2018-2023, (K Units)_x000D_

Table 16. China Gastric Motility Drugs Sales Volume Market Share by Company, 2018-2023_x000D_

Table 17. China Market, Gastric Motility Drugs Production, Sales, Import and Export, 2018-2029, (K Units)_x000D_

Table 18. China Gastric Motility Drugs Import & Export Trends_x000D_

Table 19. Main Sources of China Gastric Motility Drugs Import_x000D_

Table 20. Export Destination of China Gastric Motility Drugs_x000D_

Table 21. Global Headquarters and Manufacturing Base of Gastric Motility Drugs Manufacturers_x000D_

Table 22. Global Major Manufacturers, Gastric Motility Drugs Capacity Expansion and Future Plans_x000D_

Table 23. Global Gastric Motility Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)_x000D_

Table 24. Global Gastric Motility Drugs Production by Region, 2018-2023, (K Units)_x000D_

Table 25. Global Gastric Motility Drugs Production Forecast by Region, 2023-2029, (K Units)_x000D_

Table 26. Global Key Players of Gastric Motility Drugs Upstream (Raw Materials)_x000D_

Table 27. Global Gastric Motility Drugs Typical Customers_x000D_

Table 28. Gastric Motility Drugs Typical Distributors_x000D_

Table 29. By Type, Global Gastric Motility Drugs Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million_x000D_

Table 30. By Application, Global Gastric Motility Drugs Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million_x000D_

Table 31. By Region, Global Gastric Motility Drugs Market Size, 2018 VS 2022 VS 2029, US$ Million_x000D_

Table 32. By Region, Global Gastric Motility Drugs Revenue, 2018-2029, US$ Million_x000D_

Table 33. By Region, Global Gastric Motility Drugs Sales Volume, 2018-2029, (K Units)_x000D_

Table 34. By Country, Global Gastric Motility Drugs Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million_x000D_

Table 35. By Country, Global Gastric Motility Drugs Revenue, 2018-2029, US$ Million_x000D_

Table 36. By Country, Global Gastric Motility Drugs Revenue Market Share, 2018-2029_x000D_

Table 37. By Country, Global Gastric Motility Drugs Sales Volume, 2018-2029, (K Units)_x000D_

Table 38. By Country, Global Gastric Motility Drugs Sales Volume Market Share, 2018-2029_x000D_

Table 39. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position_x000D_

Table 40. Johnson & Johnson Gastric Motility Drugs Models, Specifications and Application_x000D_

Table 41. Johnson & Johnson Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 42. Johnson & Johnson Company Profile and Main Business_x000D_

Table 43. Johnson & Johnson Recent Developments_x000D_

Table 44. Sumitomo Dainippon Company Information, Head Office, Market Area and Industry Position_x000D_

Table 45. Sumitomo Dainippon Gastric Motility Drugs Models, Specifications and Application_x000D_

Table 46. Sumitomo Dainippon Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 47. Sumitomo Dainippon Company Profile and Main Business_x000D_

Table 48. Sumitomo Dainippon Recent Developments_x000D_

Table 49. Sanofi Company Information, Head Office, Market Area and Industry Position_x000D_

Table 50. Sanofi Gastric Motility Drugs Models, Specifications and Application_x000D_

Table 51. Sanofi Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 52. Sanofi Company Profile and Main Business_x000D_

Table 53. Sanofi Recent Developments_x000D_

Table 54. Pfizer Company Information, Head Office, Market Area and Industry Position_x000D_

Table 55. Pfizer Gastric Motility Drugs Models, Specifications and Application_x000D_

Table 56. Pfizer Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 57. Pfizer Company Profile and Main Business_x000D_

Table 58. Pfizer Recent Developments_x000D_

Table 59. Teva Company Information, Head Office, Market Area and Industry Position_x000D_

Table 60. Teva Gastric Motility Drugs Models, Specifications and Application_x000D_

Table 61. Teva Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 62. Teva Company Profile and Main Business_x000D_

Table 63. Teva Recent Developments_x000D_

Table 64. GrupoFarma Company Information, Head Office, Market Area and Industry Position_x000D_

Table 65. GrupoFarma Gastric Motility Drugs Models, Specifications and Application_x000D_

Table 66. GrupoFarma Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 67. GrupoFarma Company Profile and Main Business_x000D_

Table 68. GrupoFarma Recent Developments_x000D_

Table 69. Abbott Company Information, Head Office, Market Area and Industry Position_x000D_

Table 70. Abbott Gastric Motility Drugs Models, Specifications and Application_x000D_

Table 71. Abbott Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 72. Abbott Company Profile and Main Business_x000D_

Table 73. Abbott Recent Developments_x000D_

Table 74. Kyowa Kirin Company Information, Head Office, Market Area and Industry Position_x000D_

Table 75. Kyowa Kirin Gastric Motility Drugs Models, Specifications and Application_x000D_

Table 76. Kyowa Kirin Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 77. Kyowa Kirin Company Profile and Main Business_x000D_

Table 78. Kyowa Kirin Recent Developments_x000D_

Table 79. Sigma-Tau Group Company Information, Head Office, Market Area and Industry Position_x000D_

Table 80. Sigma-Tau Group Gastric Motility Drugs Models, Specifications and Application_x000D_

Table 81. Sigma-Tau Group Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 82. Sigma-Tau Group Company Profile and Main Business_x000D_

Table 83. Sigma-Tau Group Recent Developments_x000D_

Table 84. Wilmington Company Information, Head Office, Market Area and Industry Position_x000D_

Table 85. Wilmington Gastric Motility Drugs Models, Specifications and Application_x000D_

Table 86. Wilmington Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 87. Wilmington Company Profile and Main Business_x000D_

Table 88. Wilmington Recent Developments_x000D_

Table 89. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Company Information, Head Office, Market Area and Industry Position_x000D_

Table 90. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Models, Specifications and Application_x000D_

Table 91. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 92. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Company Profile and Main Business_x000D_

Table 93. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Recent Developments_x000D_

Table 94. Lunan Pharmaceutical Group Corporation Company Information, Head Office, Market Area and Industry Position_x000D_

Table 95. Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Models, Specifications and Application_x000D_

Table 96. Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 97. Lunan Pharmaceutical Group Corporation Company Profile and Main Business_x000D_

Table 98. Lunan Pharmaceutical Group Corporation Recent Developments_x000D_

Table 99. Hansoh Pharmaceutical Group Company Limited Company Information, Head Office, Market Area and Industry Position_x000D_

Table 100. Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Models, Specifications and Application_x000D_

Table 101. Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 102. Hansoh Pharmaceutical Group Company Limited Company Profile and Main Business_x000D_

Table 103. Hansoh Pharmaceutical Group Company Limited Recent Developments_x000D_

Table 104. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Company Information, Head Office, Market Area and Industry Position_x000D_

Table 105. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Models, Specifications and Application_x000D_

Table 106. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 107. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Company Profile and Main Business_x000D_

Table 108. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Recent Developments_x000D_

Table 109. Disha Pharmaceutical Group Co., Ltd Company Information, Head Office, Market Area and Industry Position_x000D_

Table 110. Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Models, Specifications and Application_x000D_

Table 111. Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 112. Disha Pharmaceutical Group Co., Ltd Company Profile and Main Business_x000D_

Table 113. Disha Pharmaceutical Group Co., Ltd Recent Developments_x000D_

Table 114. Xian Janssen Pharmaceutical Ltd Company Information, Head Office, Market Area and Industry Position_x000D_

Table 115. Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Models, Specifications and Application_x000D_

Table 116. Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 117. Xian Janssen Pharmaceutical Ltd Company Profile and Main Business_x000D_

Table 118. Xian Janssen Pharmaceutical Ltd Recent Developments_x000D_

List of Figure_x000D_

Figure 1. Gastric Motility Drugs Picture_x000D_

Figure 2. By Revenue, Global Gastric Motility Drugs Market Size and Forecast, 2018-2029, US$ Million_x000D_

Figure 3. By Sales Volume, Global Gastric Motility Drugs Market Size and Forecast, 2018-2029, (K Units)_x000D_

Figure 4. Global Gastric Motility Drugs Price Trend, 2018-2029, (US$/Unit)_x000D_

Figure 5. By Revenue, China Gastric Motility Drugs Market Size and Forecast, 2018-2029, US$ million_x000D_

Figure 6. By Sales Volume, China Gastric Motility Drugs Market Size and Forecast, 2018-2029, (K Units)_x000D_

Figure 7. China Gastric Motility Drugs Price Trend, 2018-2029 (US$/Unit)_x000D_

Figure 8. By Revenue, China Gastric Motility Drugs Share of Global Market, 2018-2029_x000D_

Figure 9. By Sales Volume, China Gastric Motility Drugs Share of Global Market, 2018-2029_x000D_

Figure 10. Global Gastric Motility Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023_x000D_

Figure 11. Global Gastric Motility Drugs Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022_x000D_

Figure 12. China Gastric Motility Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023_x000D_

Figure 13. China Gastric Motility Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023_x000D_

Figure 14. China Gastric Motility Drugs Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023_x000D_

Figure 15. Chinese Local Players, Proportion of Gastric Motility Drugs Domestic VS Export, 2022_x000D_

Figure 16. Global Gastric Motility Drugs Capacity, Production and Capacity Utilization, 2018-2029_x000D_

Figure 17. Global Gastric Motility Drugs Capacity Market Share by Region, 2022 VS 2029_x000D_

Figure 18. Global Gastric Motility Drugs Production Market Share & Forecast by Region, 2018-2029_x000D_

Figure 19. Gastric Motility Drugs Industry Chain_x000D_

Figure 20. Gastric Motility Drugs Procurement Model_x000D_

Figure 21. Gastric Motility Drugs Sales Model_x000D_

Figure 22. Gastric Motility Drugs Sales Channels, Direct Sales and Distribution_x000D_

Figure 23. Monotherapy_x000D_

Figure 24. Poly Pill_x000D_

Figure 25. By Type, Global Gastric Motility Drugs Revenue, 2018-2029, US$ Million_x000D_

Figure 26. By Type, Global Gastric Motility Drugs Revenue Market Share, 2018-2029_x000D_

Figure 27. By Type, Global Gastric Motility Drugs Sales Volume, 2018-2029, (K Units)_x000D_

Figure 28. By Type, Global Gastric Motility Drugs Sales Volume Market Share, 2018-2029_x000D_

Figure 29. By Type, Global Gastric Motility Drugs Price, 2018-2029, (US$/Unit)_x000D_

Figure 30. Chronic Gastritis_x000D_

Figure 31. Reflux Esophagitis_x000D_

Figure 32. Functional Dyspepsia_x000D_

Figure 33. Others_x000D_

Figure 34. By Application, Global Gastric Motility Drugs Revenue, 2018-2029, US$ Million_x000D_

Figure 35. By Application, Global Gastric Motility Drugs Revenue Market Share, 2018-2029_x000D_

Figure 36. By Application, Global Gastric Motility Drugs Sales Volume, 2018-2029, (K Units)_x000D_

Figure 37. By Application, Global Gastric Motility Drugs Sales Volume Market Share, 2018-2029_x000D_

Figure 38. By Application, Global Gastric Motility Drugs Price, 2018-2029, (US$/Unit)_x000D_

Figure 39. By Region, Global Gastric Motility Drugs Revenue Market Share, 2018-2029_x000D_

Figure 40. By Region, Global Gastric Motility Drugs Sales Volume Market Share, 2018-2029_x000D_

Figure 41. North America Gastric Motility Drugs Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 42. By Country, North America Gastric Motility Drugs Revenue Market Share, 2022_x000D_

Figure 43. Europe Gastric Motility Drugs Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 44. By Country, Europe Gastric Motility Drugs Revenue Market Share, 2022_x000D_

Figure 45. Asia Pacific Gastric Motility Drugs Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 46. By Country/Region, Asia Pacific Gastric Motility Drugs Revenue Market Share, 2022_x000D_

Figure 47. South America Gastric Motility Drugs Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 48. By Country, South America Gastric Motility Drugs Revenue Market Share, 2022_x000D_

Figure 49. Middle East & Africa Gastric Motility Drugs Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 50. U.S. Gastric Motility Drugs Sales Volume, 2018-2029, (K Units)_x000D_

Figure 51. By Company, U.S. Gastric Motility Drugs Market Share, 2022_x000D_

Figure 52. By Type, U.S. Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 53. By Application, U.S. Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 54. Europe Gastric Motility Drugs Sales Volume, 2018-2029, (K Units)_x000D_

Figure 55. By Company, Europe Gastric Motility Drugs Market Share, 2022_x000D_

Figure 56. By Type, Europe Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 57. By Application, Europe Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 58. China Gastric Motility Drugs Sales Volume, 2018-2029, (K Units)_x000D_

Figure 59. By Company, China Gastric Motility Drugs Market Share, 2022_x000D_

Figure 60. By Type, China Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 61. By Application, China Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 62. Japan Gastric Motility Drugs Sales Volume, 2018-2029, (K Units)_x000D_

Figure 63. By Company, Japan Gastric Motility Drugs Market Share, 2022_x000D_

Figure 64. By Type, Japan Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 65. By Application, Japan Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 66. South Korea Gastric Motility Drugs Sales Volume, 2018-2029, (K Units)_x000D_

Figure 67. By Company, South Korea Gastric Motility Drugs Market Share, 2022_x000D_

Figure 68. By Type, South Korea Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 69. By Application, South Korea Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 70. Southeast Asia Gastric Motility Drugs Sales Volume, 2018-2029, (K Units)_x000D_

Figure 71. By Company, Southeast Asia Gastric Motility Drugs Market Share, 2022_x000D_

Figure 72. By Type, Southeast Asia Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 73. By Application, Southeast Asia Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 74. India Gastric Motility Drugs Sales Volume, 2018-2029, (K Units)_x000D_

Figure 75. By Company, India Gastric Motility Drugs Market Share, 2022_x000D_

Figure 76. By Type, India Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 77. By Application, India Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 78. Middle East & Asia Gastric Motility Drugs Sales Volume, 2018-2029, (K Units)_x000D_

Figure 79. By Company, Middle East & Asia Gastric Motility Drugs Market Share, 2022_x000D_

Figure 80. By Type, Middle East & Asia Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 81. By Application, Middle East & Asia Gastric Motility Drugs Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 82. Research Methodology_x000D_

Figure 83. Breakdown of Primary Interviews_x000D_

Figure 84. Bottom-up Approaches_x000D_

Figure 85. Top-down Approaches_x000D_

_x000D_

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)